Medtronic, Inc., today announced that its Endeavor drug-eluting stent (DES) is the first and only coronary stent to have received CE Mark approval for treating patients with acute coronary syndrome.
Specialty
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Corporation today announced the launch of the platinum chromium TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in select markets worldwide.
Terumo Heart, Inc. Reaches Clinical Milestone with the DuraHeart™ Left Ventricular Assist System
Terumo Heart Inc. today announced reaching a critical milestone in the worldwide expansion of its DuraHeart™ Left-Ventricular Assist System (LVAS) as the 100th patient was treated with the device.
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
At six months, the NEVO™ Sirolimus-eluting Coronary Stent, incorporating RES Technology™, was superior to the Taxus® Liberte® Stent in reducing tissue growth within the stent that can potentially lead to repeat procedures, in new clinical study results released today.
Results of Medtronic-Supported implantable cardioverter-defibrillator (ICD) Clinical Trial
MVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers was applied in the MVP Trial of implantable cardioverter-defibrillator patients.
Endosense Unveils TOCCATA Trial Results: The First Complete Assessment Of Force In Catheter Ablation
Endosense has announced the release of acute clinical results from the TOCCATA (TOuCh+ for CATheter Ablation) European clinical trial at Heart Rhythm 2009, the Heart Rhythm Society’s 30th Annual Scientific Sessions in Boston, May 13 – 16.
Use Of The MitraClip® Therapy Continues To Expand In Europe, First 100 Patients Treated
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip® system in Europe.
Enrollment Complete For Medtronic Clinical Trial Evaluating Radiofrequency Ablation Tools
Medtronic, Inc. today announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial.
World Premiere Of Innovative Medical Devices For Neurosurgery
Renishaw, a world leader in engineering technologies, is introducing an exciting range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery.
Invatec Receives CE Mark Approval for the IN.PACT Admiral Drug Eluting Balloon
Invatec, a comprehensive innovator of interventional products, today announced the receipt of the CE Mark and the European launch of its IN.PACT™ Admiral paclitaxel-eluting PTA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.
What Is The Difference Between Hip Resurfacing And Total Hip Replacement?
If hip resurfacing is an option, the surgeon will simply reshape the damaged surface of the femoral ball and then cover it with a round metal cap. The limitation here is that the procedure only works for bone that is not too damaged by arthritis.
Medtronic Demonstrates Positive Results On First Pacemaker Designed For Use With MRI
New data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI™ SureScan™ pacing system experienced no complications related to the use of magnetic resonance imaging.
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
Smith & Nephew’s Orthopaedics business announced today it has made its first contribution to the Orthopaedic Research and Education Foundation for continuing medical education grants.
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers
St. Jude Medical, Inc. today announced European CE Mark approval of its Accent™ RF and Anthem™ RF CRT-P Pacemakers, equipped with wireless technology.
Boston Scientific to Donate Cardiac Rhythm Management Devices to Needy Patients
Boston Scientific Corporation today announced that it has agreed to donate Cardiac Rhythm Management devices to Heartbeat International, to implant in needy patients in countries outside the US.